Conference Call to be Held on May 19, 2022
RANCHO
CORDOVA, Calif., May 18, 2022
/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a
market leader in automated cell processing tools and services in
the cell and gene therapy field, today announced that the Company
will release its financial results for the first quarter ended
March 31, 2022 and provide a
corporate strategic update on Thursday, May
19, 2022, after the close of trading. A conference call and
webcast will follow at 1:30 p.m. PT/
4:30 p.m. ET.
To participate in the conference call, please dial
1-844-889-4331 (domestic), 1-412-380-7406 (international)
or 1-866-605-3852 (Canada). To
access a live webcast of the call, please visit:
https://thermogenesis.com/investors/news-and-events/events-webcasts/.
A webcast replay will be available on ThermoGenesis' website for
three months by visiting the Investor page of the Company's website
at www.thermogenesis.com.
About ThermoGenesis Holdings,
Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and
markets a range of automated technologies for CAR-T and other
cell-based therapies. The Company currently markets a full suite of
solutions for automated clinical biobanking, point-of-care
applications, and automation for immuno-oncology, including its
semi-automated, functionally-closed CAR-TXpress™ platform,
which streamlines the manufacturing process for the emerging CAR-T
immunotherapy market. For more information about ThermoGenesis,
please visit: www.thermogenesis.com.
Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com
Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com
View original
content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-first-quarter-ended-march-31-2022-and-provide-a-corporate-strategic-update-301549870.html
SOURCE ThermoGenesis Holdings, Inc.